Liver transplantation for type I primary hyperoxaluria as a cure for combined thrombophilia

Thrombosis and Haemostasis

Volumn 92, Issue 5, 2004, Pages 1157-1158

  Jeong, Woondong ^a   Rothberg, Paul G ^b   Delaney, Veronica ^a   Facciuto, Marcelo E ^a   Yalamanchili, Kiran ^a   Nelson, John C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CALCIUM OXALATE; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CADAVER DONOR; CASE REPORT; DEEP VEIN THROMBOSIS; DNA DETERMINATION; DNA PURIFICATION; FEMALE; GENE MUTATION; GERM LINE; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; OXALOSIS 1; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOPHILIA; URINARY EXCRETION;

EID: 9144256110     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614295     Document Type: Article

References (11)

1. Cochat P. Primary hyperoxaluria type 1. Kidney Int 1999; 55: 2533-47.
2. Scheinman JI, Alexander M, Campbell ED, et al. Transplantation for primary hyperoxaluria in the USA. Nephrol Dial Transplant 1995; 10 (Suppl 8): 42-6.
3. Astarcioglu I, Karademir S, Gulay H, et al. Primary hyperoxaluria: simultaneous combined liver and kidney transplantation from a living related donor. Liver Transpl 2003; 9: 433-6.
4. Beutler E, Lichtman MA, Coller BS, et al. Inherited deficiencies of coagulation factors. In: Williams Hematology. McGraw-Hill 2001; 1617-38.
5. Emmerich J, Rosendaal FR, Cattaneo M, et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Thromb Haemost. 2001; 86: 809-16.
6. Tan HP, Markowitz JS, Maley WR, et al. Successful liver transplantation in a patient with Budd-Chiari syndrome caused by homozygous factor V Leiden. Liver Transpl 2000; 6: 654-6.
7. Willems M, Sterneck M, Langer F, et al. Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation. Liver Transpl 2003; 9: 870-3.
8. Hirshfield G, Collier JD, Brown K, et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg 1998; 4: 58-61.
9. Favaloro EJ, Orsag I, Bukuya M, et al. A 9-year retrospective assessment of laboratory testing for activated protein C resistance: evolution of a novel approach to thrombophilia investigations. Pathology 2002; 34: 348-55.
10. Gruenewald M, Germowitz A, Beneke H, et al. Coagulation factor II activity determination is not useful as a screening tool for the G20210A prothrombin gene allele. Thromb Haemost 2000; 84: 141-2.
11. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.